Literature DB >> 11395181

Apoptosis and cell death channels in prostate cancer.

J V Tapia-Vieyra1, J Mas-Oliva.   

Abstract

Apoptosis, a type of programmed cell death, is a decisive mechanism in cell processes such as homeostasis, development, and many diseases including cancer. In mammals, the mechanisms that trigger and control the process of apoptosis are complex, because it has been observed that many molecules might be involved, acting in distinct ways and depending on the cellular type. The process of apoptosis is characterized by specific biochemical and morphologic changes. However, important specific messengers such as Ca(2)+ act in active proliferation as well as in apoptosis. At present, there is convincing evidence that a sustained increase in intracellular Ca(2)+ can activate cytotoxic mechanisms in various cells and tissues. Several ionic channels located in the cytoplasmic membrane might participate in the entry of calcium into the cytosol during apoptosis. Among these ionic channels, the purinoreceptors P2X and the channels of capacitative entry of calcium have been described. Pro- and anti-apoptotic molecules such as bax and bcl-2, respectively, have also been shown to participate in the process. We have recently found the activation of a Ca(2)+-permeable, nonselective cation channel of 23 pS conductance in prostatic cancer (LNCaP) exclusively in cells previously induced to apoptosis. Our findings are discussed taking into account the different ion channels that might participate in programmed cell death in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395181     DOI: 10.1016/s0188-4409(01)00274-0

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  12 in total

Review 1.  Role of TRP ion channels in cancer and tumorigenesis.

Authors:  George Shapovalov; Abigael Ritaine; Roman Skryma; Natalia Prevarskaya
Journal:  Semin Immunopathol       Date:  2016-02-03       Impact factor: 9.623

Review 2.  Potential roles of electrogenic ion transport and plasma membrane depolarization in apoptosis.

Authors:  R Franco; C D Bortner; J A Cidlowski
Journal:  J Membr Biol       Date:  2006-04-17       Impact factor: 1.843

Review 3.  Proapoptotic role of novel gene-expression factors.

Authors:  J V Tapia-Vieyra; P Ostrosky-Wegman; J Mas-Oliva
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.405

4.  TRP family proteins in the lower urinary tract: translating basic science into new clinical prospective.

Authors:  Massimo Lazzeri; Elisabetta Costantini; Massimo Porena
Journal:  Ther Adv Urol       Date:  2009-04

Review 5.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

6.  ARP2 a novel protein involved in apoptosis of LNCaP cells shares a high degree homology with splicing factor Prp8.

Authors:  J V Tapia-Vieyra; R O Arellano; J Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

7.  Secondary injury after musculoskeletal trauma: a review and update.

Authors:  Mark A Merrick
Journal:  J Athl Train       Date:  2002-04       Impact factor: 2.860

8.  Adenoviral-mediated pHyde gene transfer and cisplatin additively inhibit human prostate cancer growth by enhancing apoptosis.

Authors:  Yi Lu; Xiongwen Zhang; Ben Beheshti; Jun Zhang
Journal:  Prostate       Date:  2009-02-15       Impact factor: 4.104

9.  Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.

Authors:  Nicole A Lavender; Erica N Rogers; Susan Yeyeodu; James Rudd; Ting Hu; Jie Zhang; Guy N Brock; Kevin S Kimbro; Jason H Moore; David W Hein; La Creis R Kidd
Journal:  BMC Med Genomics       Date:  2012-04-30       Impact factor: 3.063

10.  ARP2, a novel pro-apoptotic protein expressed in epithelial prostate cancer LNCaP cells and epithelial ovary CHO transformed cells.

Authors:  Jaime Mas-Oliva; Enrique Navarro-Vidal; Juana Virginia Tapia-Vieyra
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.